Pharmaceutical giant Lilly announced a new billion-dollar project in Boone County, Indiana, in the LEAP Research and Innovation District. The Lilly Medicine Foundry, a $4.5 billion investment, will focus on advanced manufacturing and drug development, bringing in 400 highly skilled workers. This investment is part of Lilly’s total $13 billion investment in the LEAP district, which the company claims is the largest single investment in active pharmaceutical ingredients production in U.S. history.
Lilly’s previous investments in the LEAP district include a $2.1 billion investment in two manufacturing sites, an additional $1.6 billion, and $5.3 billion for enhancing capacity to manufacture active pharmaceutical ingredients for diabetes and obesity medicines. The state government has pledged support for infrastructure in the LEAP district, including roads, water, electricity, and other utilities.
The LEAP district has raised concerns about water usage, as the development may require drawing water from other parts of the state to sustain growth. Despite these concerns, Lilly’s ongoing investments in the district signal a commitment to innovation and development in the pharmaceutical industry. The Lilly Medicine Foundry aims to drive innovation and produce medicines for clinical trials, attracting top talent in engineering, science, and lab technology.
Overall, Lilly’s investments in the LEAP district are a significant boost to Indiana’s economy and solidify the state’s position as a hub for pharmaceutical research and development.
Source
Photo credit www.wishtv.com
